CCL19 and lymphoma: Inhibition of LTβR signaling by anti- LTβR antibody or knockdown of LTα impaired cell interaction between lymphoma cell and stromal cell, potentially by disrupting production of CCL19 and CCL21 by stromal cells which are ligands for CCR7 [31].